Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 215624
Company: APOTEX
Company: APOTEX
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| ATROPINE SULFATE | ATROPINE SULFATE | 1% | SOLUTION/DROPS;OPHTHALMIC | Prescription | AT1 | No | No |
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
|---|---|---|---|---|---|---|---|
| 11/26/2021 | ORIG-1 | Approval | STANDARD |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/215624Orig1s000ltr.pdf |
Supplements
| Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
|---|---|---|---|---|---|
| 03/09/2026 | SUPPL-8 | Labeling-Package Insert, Labeling-Medication Guide |
Label is not available on this site. |
ATROPINE SULFATE
SOLUTION/DROPS;OPHTHALMIC; 1%
TE Code = AT1
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
|---|---|---|---|---|---|---|---|---|
| ATROPINE SULFATE | ATROPINE SULFATE | 1% | SOLUTION/DROPS;OPHTHALMIC | Prescription | No | AT1 | 214752 | AMNEAL |
| ATROPINE SULFATE | ATROPINE SULFATE | 1% | SOLUTION/DROPS;OPHTHALMIC | Prescription | No | AT1 | 215624 | APOTEX |
| ATROPINE SULFATE | ATROPINE SULFATE | 1% | SOLUTION/DROPS;OPHTHALMIC | Prescription | No | AT1 | 219013 | EDENBRIDGE PHARMS |
| ATROPINE SULFATE | ATROPINE SULFATE | 1% | SOLUTION/DROPS;OPHTHALMIC | Prescription | No | AT1 | 218148 | MANKIND PHARMA |
| ATROPINE SULFATE | ATROPINE SULFATE | 1% | SOLUTION/DROPS;OPHTHALMIC | Prescription | Yes | AT1 | 206289 | RISING |
| ATROPINE SULFATE | ATROPINE SULFATE | 1% | SOLUTION/DROPS;OPHTHALMIC | Prescription | No | AT1 | 215618 | SOMERSET THERAPS LLC |